Inogen, Inc.
Inogen, Inc. (INGN) Financial Performance & Income Statement Overview
Explore the financials of Inogen, Inc. (INGN), including yearly and quarterly data on income, cash flow, and balance sheets.
Inogen, Inc. (INGN) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Inogen, Inc. INGN financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $82.28M | $80.08M | $88.83M | $88.77M |
| Cost of Revenue | $51.89M | $43.79M | $47.49M | $41.62M |
| Gross Profit | $30.39M | $36.29M | $41.34M | $47.15M |
| Gross Profit Ratio | $0.37 | $0.45 | $0.47 | $0.53 |
| R&D Expenses | $4.03M | $5.90M | $3.52M | $4.43M |
| SG&A Expenses | $39.99M | $41.78M | $45.62M | $44.19M |
| Operating Expenses | $44.03M | $47.67M | $49.14M | $53.19M |
| Total Costs & Expenses | $95.92M | $123.55M | $96.63M | $94.80M |
| Interest Income | $0.00 | $1.41M | $1.04M | $1.33M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $5.08M | $0.00 | $5.34M |
| EBITDA | -$7.66M | -$5.007M | -$7.79M | -$1.30M |
| EBITDA Ratio | -$0.09 | -$0.06 | -$0.09 | -$0.01 |
| Operating Income | -$7.66M | -$11.39M | -$7.79M | -$6.04M |
| Operating Income Ratio | -$0.09 | -$0.14 | -$0.09 | -$0.07 |
| Other Income/Expenses (Net) | $1.39M | $1.30M | $1.73M | $1.47M |
| Income Before Tax | -$6.27M | -$10.09M | -$6.06M | -$5.60M |
| Income Before Tax Ratio | -$0.08 | -$0.13 | -$0.07 | -$0.06 |
| Income Tax Expense | -$97000.00 | -$330000.00 | -$101000.00 | -$7000.00 |
| Net Income | -$6.17M | -$9.76M | -$5.96M | -$5.59M |
| Net Income Ratio | -$0.08 | -$0.12 | -$0.07 | -$0.06 |
| EPS | -$0.25 | -$0.41 | -$0.25 | -$0.24 |
| Diluted EPS | -$0.25 | -$0.41 | -$0.25 | -$0.24 |
| Weighted Avg Shares Outstanding | $25.16M | $23.65M | $23.75M | $23.61M |
| Weighted Avg Shares Outstanding (Diluted) | $25.16M | $23.65M | $23.75M | $23.61M |
Financial performance has remained strong, with revenue growing from $88.77M in Q2 2024 to $82.28M in Q1 2025. Gross profit continued to perform well, with margins at 37% in the latest quarter. Operating income reached -$7.66M in Q1 2025, holding a steady -9% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$7.66M. Net income rose to -$6.17M, keeping EPS at -$0.25. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan